Mintz advised Foster Corporation, a differentiated compounder of biomedical polymers used in the high-growth healthcare and medical device industry, on an acquisition by GEON® Performance Solutions, a global leader in the formulation, development, and manufacture of performance polymer solutions.

The addition of Foster Corporation to GEON’s portfolio will enhance GEON’s position in the high-value medical market, with Foster serving as the face of its medical end market. 

More information can be found here. 

The Mintz team that advised on the acquisition included Private Equity Co-chairs Gregory Fine and Kurt Steinkrauss, Member Katya Daniel, and Associate Zachary Liebnick. 

Mintz’s Private Equity Practice is an interdisciplinary group of transactional and regulatory attorneys who advise private equity sponsors, sellers, and portfolio company management teams, guiding them through all aspects of company growth and exits. We regularly represent both US and international sponsors and their portfolio companies, working closely with business teams to structure and execute transactions effectively and efficiently. Given the breadth and sophistication of Mintz’s buyside work with private equity sponsors, and the team’s deep understanding of the issues that pertain to rollover sellers, Mintz is routinely engaged by middle market companies looking to sell to private equity buyers.  In addition to serving as primary deal counsel on a wide range of middle-market transactional matters, we frequently serve as US subject-matter counsel in the health care, telecommunications, energy, and other sectors.